Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19

Trial Profile

At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 08 Jan 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Bamlanivimab (Primary)
  • Indications COVID-19 respiratory infection
  • Focus Therapeutic Use
  • Acronyms UNITED
  • Most Recent Events

    • 05 Jan 2021 Status changed from not yet recruiting to recruiting.
    • 18 Dec 2020 According to an Eli Lilly and Company media release, this study will be conducted in New Mexico in collaboration with major local institutions in the state of New Mexico. This study will begin in the coming weeks.
    • 14 Dec 2020 New trial record
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with a username/password associated to your organization’s account.
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Federated access using single sign-on credentials.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top